Live from the NIH registry
Studies recruiting near Erie right now
Top 25 of 92 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
Diabetic Macular Edema
Phase 1
Interventional 93 participants sought
Erie Retina Research, LLC - 300 State St — Erie, Pennsylvania (1.1 mi)
· Sponsor: Genentech, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi)
· Sponsor: SWOG Cancer Research Network
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigative Site 9924 — Westfield, New York (29.0 mi)
· Sponsor: Anthos Therapeutics, Inc.
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Erie, Pennsylvania (1.1 mi)
· Sponsor: Medtronic
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Neovascular Age-Related Macular Degeneration (nAMD)
Phase 3
Interventional 480 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi)
· Sponsor: 4D Molecular Therapeutics
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Saint Vincent Hospital — Erie, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
Study of ALK-001 on the Progression of Stargardt Disease
Stargardt Disease
Phase 3
Interventional 230 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi)
· Sponsor: Alkeus Pharmaceuticals, Inc.
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi)
· Sponsor: EyeBiotech Ltd.
Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
Neovascular (Wet) Age-Related Macular Degeneration
Phase 1, Phase 2
Interventional 30 participants sought
Erie, PA — Erie, Pennsylvania (1.1 mi)
· Sponsor: Eyconis INC.
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD
Dry Age-related Macular Degeneration
Phase 3
Interventional 237 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi)
· Sponsor: Ocugen
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Cutaneous Melanoma
Phase 3
Interventional 428 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study in Adults With Geographic Atrophy
Geographic Atrophy
Phase 2
Interventional 300 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi)
· Sponsor: Sitala Bio LTD
A Study to Assess the Efficacy and Safety of RO7965032 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Geographic Atrophy Secondary to Age-Related Macular Degeneration
Phase 2
Interventional 321 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi)
· Sponsor: Genentech, Inc.
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi)
· Sponsor: NRG Oncology
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Center Involved Diabetic Macular Edema, Diabetic Macular Edema
Phase 1
Interventional 24 participants sought
Erie Retina Research, LLC — Erie, Pennsylvania (1.1 mi)
· Sponsor: Ocugen
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
UPMC Hillman Cancer Center Erie — Erie, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
Obesity
Phase 2
Interventional 230 participants sought
Great Lakes Medical Research — Westfield, New York (29.0 mi)
· Sponsor: Novo Nordisk A/S
Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
Age-related Wet Macular Degeneration
Phase 1
Interventional 45 participants sought
CBCC Global Research Site:002 — Erie, Pennsylvania (1.1 mi)
· Sponsor: Caregen Co. Ltd.
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
Macular Edema Secondary to Inflammation
Phase 3
Interventional 300 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi)
· Sponsor: Kodiak Sciences Inc
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Westfield, New York (29.0 mi)
· Sponsor: Alnylam Pharmaceuticals
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Diabetic Macular Edema, DME
Phase 3
Interventional 240 participants sought
Erie Retina Research — Erie, Pennsylvania (1.1 mi)
· Sponsor: EyePoint Pharmaceuticals, Inc.